Finding 978215 (2023-001)

Significant Deficiency Repeat Finding
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2024-06-24
Audit: 309693
Auditor: Bdo

AI Summary

  • Core Issue: PSI's internal control process for reviewing and approving expenditures is not functioning as intended, leading to misreported expenses.
  • Impacted Requirements: Compliance with federal financial management standards (§200.302 and §200.303) is at risk due to inadequate adherence to established policies.
  • Recommended Follow-Up: PSI should reinforce training on its expenditure policies to ensure timely approval and accurate recording of costs.

Finding Text

Internal Control over Compliance and Compliance with Activities Allowed or Unallowed and Allowable Costs and Cost Principles See Schedule of Findings and Questioned Costs for chart/table. Criteria or Specific Requirement: In accordance with §200.302 Financial Management, a non-federal entity's financial management systems, including records documenting compliance with federal statutes, regulations, and the terms and conditions of the federal award, must be sufficient to permit the preparation of reports required by general and program-specific terms and conditions; and the tracing of funds to a level of expenditures adequate to establish that such funds have been used according to the federal statutes, regulations, and the terms and conditions of the federal award. The financial management system of each non-federal entity must provide for the following: (1) Identification, in its accounts, of all federal awards received and expended and the federal programs under which they were received. (2) Accurate, current, and complete disclosure of the financial results of each federal award or program in accordance with the reporting requirements set forth in §200.327 Financial Reporting and §200.328 Monitoring and Reporting Program Performance. (3) Records that identify adequately the source and application of funds for federally-funded activities. (4) Effective control over, and accountability for, all funds, property, and other assets. Additionally, §200.303 Internal Controls states that a non-federal entity must (a) establish and maintain effective internal control over the federal award that provides reasonable assurance that the non-federal entity is managing the federal award in compliance with federal statutes, regulations, and the terms and conditions of the federal award. Condition: PSI has documented expenditure policies and procedures. However, as identified below, the review and approval process did not operate as designed. PSI’s policies are designed to ensure expenses are reviewed and approved timely to ensure proper recording in the books and records. The following errors were identified during our testing of payroll and non-payroll expenditures: For AL# 12.350 and AL# 98.001, BDO tested 120 payroll and non-payroll expenditures for each major program. BDO also separately tested 40 transactions from the indirect cost pool. Based on that testing, BDO identified instances in which the expenditures were reported within the incorrect period on an accrual basis. These expenditures were valid expenditures within the overall award period. o For AL# 98.001 we identified the following errors: See Schedule of Findings and Questioned Costs for chart/table. o For AL# 12.350 we identified the following error: See Schedule of Findings and Questioned Costs for chart/table. o For indirect cost pool testing, one of the 40 transactions tested totaling $9 was recorded in error as it related to a prior period (2022). Questioned Costs: As all of the costs noted were within the award period of performance, there are no questioned costs to report. Context: This is a condition identified per review of PSI’s compliance with allocability and allowability provisions of the Uniform Guidance. The prevalence of these findings is detailed in the condition section above. Samples were selected using a non-statistical method. Cause: PSI has documented expenditure policies and procedures regarding the timely processing and approval of expenditures incurred. However, as identified above, the review and approval process for the samples identified above did not operate as designed. Effect: The lack of adherence to established internal control policies and procedures can lead to noncompliance with federal statutes, regulations, and the provisions of award agreements which could ultimately lead to disallowed costs for the major programs. Repeat Finding: This is a repeat finding from the previous year. This was reported as finding 2022-002 in the 2022 schedule of findings and questioned costs. Recommendation: BDO recommends PSI adhere to its documented policies and procedures regarding authorization and timely approval and recording of expenditures. Views of Responsible Officials: PSI management agrees with the finding and recommendations set forth within and will provide additional training to staff members to ensure compliance with established policies and procedures. Refer to management’s corrective action plan for additional information.

Categories

Allowable Costs / Cost Principles Subrecipient Monitoring Period of Performance Reporting Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 401766 2023-001
    Significant Deficiency Repeat
  • 401767 2023-002
    Significant Deficiency
  • 401768 2023-004
    Significant Deficiency Repeat
  • 401769 2023-003
    Significant Deficiency Repeat
  • 401770 2023-003
    Significant Deficiency Repeat
  • 401771 2023-002
    Significant Deficiency
  • 401772 2023-003
    Significant Deficiency Repeat
  • 401773 2023-001
    Significant Deficiency Repeat
  • 401774 2023-002
    Significant Deficiency
  • 401775 2023-004
    Significant Deficiency Repeat
  • 401776 2023-005
    Significant Deficiency Repeat
  • 401777 2023-002
    Significant Deficiency
  • 401778 2023-004
    Significant Deficiency Repeat
  • 401779 2023-005
    Significant Deficiency Repeat
  • 401780 2023-002
    Significant Deficiency
  • 401781 2023-004
    Significant Deficiency Repeat
  • 401782 2023-004
    Significant Deficiency Repeat
  • 401783 2023-004
    Significant Deficiency Repeat
  • 401784 2023-003
    Significant Deficiency Repeat
  • 401785 2023-001
    Significant Deficiency Repeat
  • 401786 2023-001
    Significant Deficiency Repeat
  • 978208 2023-001
    Significant Deficiency Repeat
  • 978209 2023-002
    Significant Deficiency
  • 978210 2023-004
    Significant Deficiency Repeat
  • 978211 2023-003
    Significant Deficiency Repeat
  • 978212 2023-003
    Significant Deficiency Repeat
  • 978213 2023-002
    Significant Deficiency
  • 978214 2023-003
    Significant Deficiency Repeat
  • 978216 2023-002
    Significant Deficiency
  • 978217 2023-004
    Significant Deficiency Repeat
  • 978218 2023-005
    Significant Deficiency Repeat
  • 978219 2023-002
    Significant Deficiency
  • 978220 2023-004
    Significant Deficiency Repeat
  • 978221 2023-005
    Significant Deficiency Repeat
  • 978222 2023-002
    Significant Deficiency
  • 978223 2023-004
    Significant Deficiency Repeat
  • 978224 2023-004
    Significant Deficiency Repeat
  • 978225 2023-004
    Significant Deficiency Repeat
  • 978226 2023-003
    Significant Deficiency Repeat
  • 978227 2023-001
    Significant Deficiency Repeat
  • 978228 2023-001
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
98.U00 Usaid Cost Reimbursable Contracts and Other Awards $8.63M
98.001 Usaid Foreign Assistance for Programs Overseas $6.30M
98.001 Covid 19 - Usaid Foreign Assistance for Programs Overseas $145,831
12.350 Department of Defense Hiv/aids Prevention Program $54,674
93.318 Covid 19 - Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $-275
93.067 Global Aids $-6,695
98.U00 Covid 19 - Usaid Cost Reimbursable Contracts and Other Awards $-178,808